[Clinical and radiological evaluation of Reogan therapy of periapical dental tissue inflammations].
D000293:Adolescent; D000328:Adult; D001466:Barium Sulfate / Q000627:therapeutic use*; D001861:Bone Regeneration / Q000187:drug effects; D002126:Calcium Hydroxide / Q000627:therapeutic use*; D002364:Caseins / Q000627:therapeutic use*; D003790:Dental Pulp Necrosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D008276:Magnesium Hydroxide / Q000627:therapeutic use*; D008875:Middle Aged; D010485:Periapical Periodontitis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011859:Radiography
D002364:Caseins; D004338:Drug Combinations; D001466:Barium Sulfate; C029079:barium sulfate mixt. with calcium hydroxide, caseins and magnesium hydroxide; D008274:Magnesium; D008276:Magnesium Hydroxide; D002126:Calcium Hydroxide
Ocena kliniczna i radiologiczna leczenia zapaleń tkanek okołowierzchołkowych zebów preparatem Reogan.